What is a stock summary page? Click here for an overview.
Business Description
Rakovina Therapeutics Inc
NAICS : 541714
SIC : 3741
Description
Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some of its products in the pipeline include kt-2000 AI, kt-3000 series. Rakovina gained exclusive use of the Deep Docking AI Platform, enabling it to significantly speed up identifying potential drugs for DNA damage response.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | -0.56 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.48 | |||||
| 9-Day RSI | 45.48 | |||||
| 14-Day RSI | 45.2 | |||||
| 3-1 Month Momentum % | 125 | |||||
| 6-1 Month Momentum % | 125 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 0.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.69 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -92.99 | |||||
| ROA % | -61.07 | |||||
| ROIC % | -68.7 | |||||
| ROC (Joel Greenblatt) % | -2838.82 | |||||
| ROCE % | -61.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.79 | |||||
| EV-to-EBIT | -3.19 | |||||
| EV-to-EBITDA | -3.87 | |||||
| EV-to-FCF | -3.93 | |||||
| Earnings Yield (Greenblatt) % | -31.35 | |||||
| FCF Yield % | -28.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RKVTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rakovina Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.028 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 45.2 | ||
| 14-Day ATR ($) | 0.035186 | ||
| 20-Day SMA ($) | 0.07594 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.06 - 10 | ||
| Shares Outstanding (Mil) | 90.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rakovina Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rakovina Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rakovina Therapeutics Inc Frequently Asked Questions
What is Rakovina Therapeutics Inc(RKVTF)'s stock price today?
The current price of RKVTF is $0.07. The 52 week high of RKVTF is $10.00 and 52 week low is $0.06.
When is next earnings date of Rakovina Therapeutics Inc(RKVTF)?
The next earnings date of Rakovina Therapeutics Inc(RKVTF) is .
Does Rakovina Therapeutics Inc(RKVTF) pay dividends? If so, how much?
Rakovina Therapeutics Inc(RKVTF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers